Predictive Value of P Wave Terminal Force in Lead V1 for Atrial Fibrillation: A Meta-analysis

Overview

Journal Ann Noninvasive Electrocardiol

Specialty Cardiology & Vascular Diseases

Date 2020 Feb 6

PMID 32022368

Citations 30

Authors

Zhuoshan Huang

Zhenda Zheng

Bingyuan Wu

LeiLe Tang

Xujing Xie

Ruimin Dong

Yanting Luo

Suhua Li

Jieming Zhu

Jinlai Liu

Affiliations

Soon will be listed here.

Abstract

Background: Several studies have explored the association between P wave terminal force in lead V1 (PTFV1) and risk of atrial fibrillation (AF) occurrence, but the results were controversial. This meta-analysis aimed to examine whether abnormal PTFV1 could predict AF occurrence.

Methods: We searched PubMed, Embase, and Cochrane Library databases for articles published before August 25, 2018. Pooled odds ratios (ORs) of AF occurrence were calculated using random-effects models to explore the significance of PTFV1.

Results: A total of 12 studies examining 51,372 participants were included, with 9 studies analyzing PTFV1 as a categorical variable and 4 studies analyzing PTFV1 as a continuous variable. As a categorical variable, abnormal PTFV1 (>0.04 mm s) was significantly associated with AF occurrence with a pooled OR of 1.39 (95% confidence interval [CI] 1.08-1.79, p = .01). Subgroup analysis found that ORs of studies in hemodialysis patients (OR = 4.89, 95% CI 2.54-9.90, p < .001) and acute ischemic stroke patients (OR = 1.60, 95% CI 1.14-2.25, p = .007) were higher than general population (OR = 1.15, 95% CI 1.03-1.29, p = .01). Studies from Europe (OR = 1.05, 95% CI 0.91-1.20, p = .51) yielded lower OR of endpoints compared with Asia (OR = 1.89, 95% CI 1.38-2.60, p < .001) and United States (OR = 1.43, 95% CI 1.19-1.72, p < .001). As a continuous variable, PTFV1 was also significantly associated with AF occurrence with a polled OR per 1 standard deviation (SD) change of 1.27 (95% CI 1.02-1.59, p = .03).

Conclusions: PTFV1 was significantly associated with the risk of AF and was considered to be a good predictor of AF occurrence in population with or without cardiovascular diseases.

Citing Articles

Clinical, Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation Recurrence After Pulmonary Vein Isolation.

Karanikola A, Tzortzi M, Kordalis A, Doundoulakis I, Antoniou C, Laina A J Clin Med. 2025; 14(3).

PMID: 39941478 PMC: 11818469. DOI: 10.3390/jcm14030809.

Arterial Stiffness and Markers of Atrial Myopathy.

Okrajni M, Platonov P, Muhammad I, Holmqvist F, Lundberg J, Persson A Ann Noninvasive Electrocardiol. 2025; 30(2):e70044.

PMID: 39888124 PMC: 11783235. DOI: 10.1111/anec.70044.

The Value of P-Wave Parameters Changes in Predicting Catheter Ablation Outcomes for Paroxysmal Atrial Fibrillation.

Antoun I, Li X, Vali Z, Kotb A, Abdelrazik A, Koev I Ann Noninvasive Electrocardiol. 2024; 30(1):e70047.

PMID: 39739528 PMC: 11686087. DOI: 10.1111/anec.70047.

Digital Electrocardiographic Complex for Risk Stratification of Paroxysmal Atrial Fibrillation.

Frolov A, Melnikova O, Vorobiev A, Vaikhanskaya T Sovrem Tekhnologii Med. 2024; 16(3):43-48.

PMID: 39650275 PMC: 11618526. DOI: 10.17691/stm2024.16.3.05.

P-wave terminal force is related to left pulmonary vein reconnection in patients with atrial fibrillation recurrence after pulmonary vein isolation.

Wakabayashi Y, Uesako H, Kobayashi M, Ichikawa T, Koyama T, Abe H Heart Vessels. 2024; .

PMID: 39348036 DOI: 10.1007/s00380-024-02472-9.

References

Huang Z, Zheng Z, Wu B, Tang L, Xie X, Dong R . Predictive value of P wave terminal force in lead V1 for atrial fibrillation: A meta-analysis. Ann Noninvasive Electrocardiol. 2020; 25(4):e12739. PMC: 7358887. DOI: 10.1111/anec.12739. View

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

Josephson M, Kastor J, Morganroth J . Electrocardiographic left atrial enlargement. Electrophysiologic, echocardiographic and hemodynamic correlates. Am J Cardiol. 1977; 39(7):967-71. DOI: 10.1016/s0002-9149(77)80209-9. View

German D, Kabir M, Dewland T, Henrikson C, Tereshchenko L . Atrial Fibrillation Predictors: Importance of the Electrocardiogram. Ann Noninvasive Electrocardiol. 2015; 21(1):20-9. PMC: 4728003. DOI: 10.1111/anec.12321. View

Staerk L, Sherer J, Ko D, Benjamin E, Helm R . Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res. 2017; 120(9):1501-1517. PMC: 5500874. DOI: 10.1161/CIRCRESAHA.117.309732. View

Sanna T, Diener H, Passman R, Di Lazzaro V, Bernstein R, Morillo C . Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014; 370(26):2478-86. DOI: 10.1056/NEJMoa1313600. View

Magnani J, Zhu L, Lopez F, Pencina M, Agarwal S, Soliman E . P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2014; 169(1):53-61.e1. PMC: 4269236. DOI: 10.1016/j.ahj.2014.10.009. View

Healey J, Connolly S, Gold M, Israel C, Van Gelder I, Capucci A . Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012; 366(2):120-9. DOI: 10.1056/NEJMoa1105575. View

Win T, Ambale Venkatesh B, Volpe G, Mewton N, Rizzi P, Sharma R . Associations of electrocardiographic P-wave characteristics with left atrial function, and diffuse left ventricular fibrosis defined by cardiac magnetic resonance: The PRIMERI Study. Heart Rhythm. 2014; 12(1):155-62. PMC: 4277898. DOI: 10.1016/j.hrthm.2014.09.044. View

10.

Tse G, Wong C, Gong M, Wong W, Bazoukis G, Wong S . Predictive value of inter-atrial block for new onset or recurrent atrial fibrillation: A systematic review and meta-analysis. Int J Cardiol. 2017; 250:152-156. DOI: 10.1016/j.ijcard.2017.09.176. View

11.

Soliman E, Prineas R, Case L, Zhang Z, Goff Jr D . Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2009; 40(4):1204-11. PMC: 2685189. DOI: 10.1161/STROKEAHA.108.534735. View

12.

Gladstone D, Spring M, Dorian P, Panzov V, Thorpe K, Hall J . Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014; 370(26):2467-77. DOI: 10.1056/NEJMoa1311376. View

13.

Greenland S . Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987; 9:1-30. DOI: 10.1093/oxfordjournals.epirev.a036298. View

14.

Ling L, Kistler P, Kalman J, Schilling R, Hunter R . Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol. 2015; 13(3):131-47. DOI: 10.1038/nrcardio.2015.191. View

15.

Lee R, Mittal S . Utility and limitations of long-term monitoring of atrial fibrillation using an implantable loop recorder. Heart Rhythm. 2017; 15(2):287-295. DOI: 10.1016/j.hrthm.2017.09.009. View

16.

Baturova M, Sheldon S, Carlson J, Brady P, Lin G, Rabinstein A . Electrocardiographic and Echocardiographic predictors of paroxysmal atrial fibrillation detected after ischemic stroke. BMC Cardiovasc Disord. 2016; 16(1):209. PMC: 5093933. DOI: 10.1186/s12872-016-0384-2. View

17.

Kamel H, Soliman E, Heckbert S, Kronmal R, Longstreth Jr W, Nazarian S . P-wave morphology and the risk of incident ischemic stroke in the Multi-Ethnic Study of Atherosclerosis. Stroke. 2014; 45(9):2786-8. PMC: 4146624. DOI: 10.1161/STROKEAHA.114.006364. View

18.

He J, Tse G, Korantzopoulos P, Letsas K, Ali-Hasan-Al-Saegh S, Kamel H . P-Wave Indices and Risk of Ischemic Stroke: A Systematic Review and Meta-Analysis. Stroke. 2017; 48(8):2066-2072. DOI: 10.1161/STROKEAHA.117.017293. View

19.

Benjamin E, Wolf P, DAgostino R, Silbershatz H, Kannel W, Levy D . Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98(10):946-52. DOI: 10.1161/01.cir.98.10.946. View

20.

Nishi K, Fujimoto S, Hisanaga S, Ogawa O, Kitamura K . Electrocardiographic assessment of incident atrial fibrillation in hemodialysis patients. Ther Apher Dial. 2013; 17(1):16-23. DOI: 10.1111/j.1744-9987.2012.01137.x. View